Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:IDO inhibitor 12 CAS:1888341-29-4 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- Basic information |
Product Name: | 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- | Synonyms: | 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]-;IDO-IN-12;IDO inhibitor 12;4-(3-bromo-4-fluorophenyl)-3-(4-((2-(methylthio)ethyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one;inhibit,Indoleamine 2,3-Dioxygenase (IDO),Inhibitor,IDOIN12,IDO IN 12 | CAS: | 1888341-29-4 | MF: | C13H11BrFN5O3S | MW: | 416.23 | EINECS: | | Product Categories: | | Mol File: | 1888341-29-4.mol | ![1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- Structure](CAS/20180528/GIF/1888341-29-4.gif) |
| 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- Chemical Properties |
Boiling point | 555.9±60.0 °C(Predicted) | density | 1.84±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : ≥ 50 mg/mL (120.13 mM) | pka | -0.66±0.10(Predicted) | form | Solid | color | White to off-white |
| 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- Usage And Synthesis |
Description | IDO-IN-12 is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO 2017181849 A1. | References | [1]. Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1. |
| 1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]- Preparation Products And Raw materials |
|